LLY:NYSE
Eli Lilly And Co
$1,142.85
arrow_downward
-0.61%(-7.00) 1D
$1,143.60
arrow_upward
+0.07% (+0.75)bedtimePagkalipas ng oras ng trabaho
Sarado: Okt 2, 4:00:05 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa LLY...
Buksan
$1,153.82
Mataas
$1,164.92
Mababa
$1,136.66
Mkt. cap
1.08T
Avg. na dami
2.36M
Dami
2.05M
Dividend
0.61%
Bawat tatlong buwang dividend
$1.73
Petsa ng ex-dividend
Ago 14, 2026
P/E ratio
38.36
Mataas nang 52-wk
$1,292.65
Mababa nang 52-wk
$783.85
EPS
$29.80
Beta
0.46
Mga natitirang share
941.36M
Bilang ng mga empleyado
50K
Buksan
$1,153.82
Mataas
$1,164.92
Mababa
$1,136.66
Mkt. cap
1.08T
Avg. na dami
2.36M
Dami
2.05M
Dividend
0.61%
Bawat tatlong buwang dividend
$1.73
Petsa ng ex-dividend
Ago 14, 2026
P/E ratio
38.36
Mataas nang 52-wk
$1,292.65
Mababa nang 52-wk
$783.85
EPS
$29.80
Beta
0.46
Mga natitirang share
941.36M
Bilang ng mga empleyado
50K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Longevity.Technology
·
2 oras ang nakalipas
Lilly and Novo share GLP-1 longevity data
AD HOC NEWS
·
4 oras ang nakalipas
Eli Lilly expands Jaypirca use as Eli Lilly stock trades EUR 1016.60 flat
Mugglehead Investment Magazine
·
9 oras ang nakalipas
Eli Lilly and Company gains FDA Jaypirca approval
AD HOC NEWS
·
10 oras ang nakalipas
Eli Lilly stock falls 0.61 percent as pipeline data arrive
Profile
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
Tungkol sa Eli Lilly And Co
CEODavid A. Ricks
Mga Empleyado50K
Itinatag1876
HeadquartersIndianapolis, Indiyana, Estados Unidos
Sektor-
Websitelilly.com